download full program and abstracts

This is the 15th in a series of workshops dealing with the immunology of the skin. Early on, the focus was almost exclusively on epidermal Langerhans cells.  More recently, the scope has broadened to other types of antigen presenting cells of the skin.  The skin, with its diverse spectrum of immune cells, remains an attractive target for immunotherapeutic approaches directed against inflammatory and infectious skin diseases and cancers.  The past Langerhans Cell Workshops have impressively documented these developments.  Talks and posters will again be addressing these important topics.

The biannual LC Workshops fosters productive interactions between established and young investigators. Prior workshops have led to productive collaborations and important advances in cutaneous immunology and Langerhans cell immunobiology in particular.  LC2017 will again be a very interactive and fruitful scientific meeting.

Langerhans Cell Workshops have always given fresh impetus to the immunological field of dendritic cells. We would very much like to see the field not only maintain but also increase this momentum and ongoing productivity.  We therefore cordially invite you to participate in the 15th International Workshop on Langerhans Cells in New York, which will take place from Friday morning, October 6th through Sunday afternoon, October 8th, 2017.

We look forward to seeing you at Memorial Sloan Kettering Cancer Center in New York City in October 2017!


Jim Young, Conference Chair

Miriam Merad, Dan Kaplan, Niki Romani, and Kenji Kabashima


INVITED SPEAKERS (in alphabetical order)

Niroshana Anandasabapathy, Brigham and Woman’s Hospital, Boston, MA, USA

Co-opting of homeostatic tissue DC development in the tumor microenvironment


Carl E. Allen, Texas Children’s Hospital, Houston, TX, USA 

Langerhans Cell Histiocytosis: A human model of DC differentiation and function


Clare Bennett, University College London, London, UK 

Defining a novel role for LC in the epidermis – LC are required for cutanous GVHD by directly activating a unique programme of pathogenicity  in effector T cells


Björn Clausen, University Medical Center, Mainz, Germany

Cellular and molecular players driving psoriatic skin disease in mice


Matthew Collin, Newcastle University, Newcastle upon Tyne, UK

The role of donor myeloid cells in human graft versus host disease of the skin


 Emma Guttman, Mount Sinai, New York, NY, USA

Atopic dermatitis is driven by a network of T-cells and dendritic cells


Muzlifah Haniffa, Newcastle University, Newcastle upon Tyne, UK

Deconstructing the human skin using single cell technologies


Sandrine Henri, Centre d’Immunologie Marseille-Luminy, Marseille, France

Unveiling melanophage dynamics : Insights from a new mouse model


Kenji Kabashima, Kyoto University, Kyoto, Japan

Role of skin dendritic cells in the elicitation phase of acquired immune responses


Daniel Kaplan, University of Pittsburgh, Pittsburg, PA, USA

Non-hematopoetic control of skin immunity


Eynav Klechevsky, Washington University, Saint Louis, MO, USA

Human Langerhans Cell Subsets in control of cutaneous immunity


Sergei Koralov, NYU School of Medicine, New York, NY, USA

Analysis of molecular etiology and bacterial triggers of Cutaneous T cell lymphoma


James Krueger, The Rockefeller University, New York, NY, USA

Psoriasis and dendritic cell involvement


Miriam Merad, Mount Sinai Hospital, New York, NY, USA

Langerhans cell histiocytosis:  human and mouse models


Shruti Naik, The Rockefeller University, New York, NY, USA

Memory of Inflammation in Epidermal Stem Cells


Alexander Rudensky, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Differentiation and function of regulatory T cells


Patrizia Stoitzner, Medical University of Innsbruck, Innsbruck, Austria

Skin dendritic cells in cancer immunity: can they be harnessed for immunotherapy?


Florian Winau, Harvard Medical School, Boston, MA, USA

Revisiting the importance of CD1a on Langerhans cells